Buenas tardes....
Aquí sigo tras unas mini vacaciones de viernes a martes....
Las CASI hoy petando bien...
Es un valor que mueve muy poco volumen...
Es la antigua ENTREMED (ENMD)....
Yo mantengo AGEN, ARRY, CTIX y DMPI, pero no hay manera que ninguna salte como las CASI hoy....
Veremos si la conferencia del 17 en Orlando sirve para subir el precio..
DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer
DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer
Download as PDF SEPTEMBER 02, 2015
Company to Present Data at AACR Advances in Ovarian Cancer Research: Exploiting Vulnerabilities Conference
VANCOUVER, British Columbia and MENLO PARK, Calif., Sept. 2, 2015 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it will present an abstract entitled, "A Comparison of the Mechanisms and Cytotoxic Activity of Dianhydrogalactitol (VAL-083) to Cisplatin in Ovarian Tumor Models Harboring Wild-type and Mutant p53," at the American Association for Cancer Research (AACR) Advances in Ovarian Cancer Research: Exploiting Vulnerabilities Conference being held October 17-20, 2015 in Orlando, FL.
The presentation will summarize VAL-083's potential as a new treatment for ovarian cancer in the context of DelMar's recent research and historical data from prior NCI-sponsored clinical trials.